144 results
424B3
SEEL
Seelos Therapeutics Inc
15 Mar 24
Prospectus supplement
4:15pm
, $0.001 par value.
Common Stock
Voting Rights. Holders of common stock are entitled to one vote per share for the election of directors and on all other … matters that require stockholder approval. Holders of common stock do not have any cumulative voting rights.
Liquidation Rights. Subject to any
8-K
EX-4.1
fiub5dxsdmd9hk3zdh0g
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
424B5
iv6mmnszm
30 Jan 24
Prospectus supplement for primary offering
6:05am
8-K
t49ut8t4z xxcl1o
10 Jan 24
Material Modifications to Rights of Security Holders
4:16pm
8-K
EX-4.2
e7rklx6q3if11l96f
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-4.1
uoocd
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
siqgrq p8to
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
gi08opbeabo di
28 Nov 23
Prospectus supplement for primary offering
4:06pm
8-K
yaiiv7r j69ofxyt
28 Nov 23
Material Modifications to Rights of Security Holders
9:00am
424B3
jjwixszuqrq 9e4dju7
29 Sep 23
Prospectus supplement
4:56pm
8-K
EX-4.1
evcuhtw
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm